Publication | Closed Access

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials

Hematological MalignancyLymphoid NeoplasiaFront-line TherapyChronic Lymphocytic LeukaemiaMedicineControlled Clinical TrialsHematologyClinical TrialsPharmacotherapyCancer TreatmentImmunotherapyOncologyRadiation OncologyHealth Sciences